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ABSTRACT
Necrotic enteritis (NE) has re-emerged following restriction of antimicrobial usage and costs $6
billion every year worldwide. The primary objective of the studies was to evaluate prevention and
treatment of NE using a microbiota metabolic product, secondary bile acid deoxycholic acid
(DCA), in drinking water. Day-old birds were tagged and placed in floor pens. In experiments 1
and 2, the birds were infected with Eimeria maxima (Em) at d 18 and C. perfringens at d 23 and
24 and the birds were euthanized at d 26. In experiment 3, birds were infected with Eimeria at d
20 and C. perfringens at d 25 and 26 and euthanized at d 27. DCA was administered in drinking
water at 1.91, 0.95, or 0.48 mM, respectively. Small intestinal content and tissue were collected
for histopathology and molecular study. Data were analyzed using one-way ANOVA followed by
t-test. NE birds in experiment 1 developed subclinical signs of NE, while NE birds in experiment
3 suffered acute NE. DCA at 1.91 mM attenuated the BWG loss in experiments 1 and 3.
Consistently, it reduced NE-induced intestinal histopathology in experiments 1 and 3. However,
in experiment 2 because of minimal body weight alteration in Em and NE birds compared to noninfected birds, no tissue was collected. DCA reduced NE-induced expression of inflammatory gene
Infγ in experiment 1. Similarly, DCA reduced elevation of NE-associated C. perfringens luminal
colonization in experiment 1. Using targeted metabolomics (LC-MS/MS) of bile acids, we found
that NE was associated with reduction of total bile acids in ileal content.
The second objective of the studies was to examine improvement of broiler chickens growth
through modulating gut microbiota. Mouse specific pathogen free (SPF) stool was cultured on
Brain Heart Infusion (BHI) agar under anaerobic or aerobic condition and collected as SPF
anaerobic (SPF-Anaero) and aerobic (SPF-Aero) microbiota. Day-old birds were tagged, weighed
and randomly assigned to 9 pens. The birds were then orally gavaged with PBS, 10 8 CFU/bird

SPF-Anaero, or 108 CFU/bird SPF-Aero. Body weight was measured at d 0, 14, and d 28, and
euthanized at d 28. Data was analyzed using one-way ANOVA followed by t-test. Birds colonized
with SPF-Anaero grew 15% heavier during d 0-14 (28 vs. 24 g/day/bird, P= 0.0009) compared to
control birds, while birds colonized with SPF-Aero gained 8% more body weight compared to
control birds (26 vs. 24 g/day /bird, P= 0.02). Consistently, SPF-Anaero birds grew faster
compared to control birds during d14-28 (67 vs. 60 g/day/bird, P= 0.007). SPF-Anaero and SPFAero birds grew 15 and 4%, respectively, heavier on accumulative body weight gain compared to
control birds (47 vs. 42 g/day/bird, P= 0.0009; 44 vs. 42 g/day/bird, P= 0.03, respectively).
In conclusion, microbial metabolic product DCA in drinking water prevents NE-induced BWG
reduction and histopathology, perhaps through reducing C. perfringens colonization and/or bile
acid restoration. Modulating microbiota could be used as an antimicrobial free alternative to
improve bird body weight gain. These findings may offer an alternative strategy to use of DCA
and microbiota for NE prevention and growth promotion.
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Literature Review
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1.1. Introduction
Before the current name, necrotic enteritis (NE) caused by C. perfringens was first called Bacillus
welchii, then renamed to Clostridium welchii, from intestinal lesions of Black Orpington pullets
in 1930 by Bennetts, in Australia (Bennetts, 1930). Later on, the disease was induced by feeding
C. perfringens culture to chickens and called the "six-day disease," when the bacteria were
observed to infect intestinal mucosa of the birds (Johansson & Sarles, 1948). However, the term
necrotic enteritis was coined and reported by Parish in 1961 in England (Parish, 1961). After the
discovery of NE, methods had been developed to control the disease. Antibiotics were first used
for NE prevention and treatment, and later on they are used as growth promoters. Antibiotic growth
promoters (AGPs) have been widely used in food animal production for decades (Stokstad &
Jukes, 1950). For example, in 1951, the United States Food and Drug Administration permitted
the use of antibiotics in animal feed (F. T. Jones & Ricke, 2003). Before AGPs were banned by
the European Union (EU) in 2006, antibacterial drugs, such as avoparcin, lincomycin, amoxicillin,
tylosin virginiamycin, and bacitracin, were commonly used for both prevention and treatment of
NE (Craven et al., 2001; McDevitt et al., 2006a). However, after observing the effects of AGPs on
the development and expansion of drug-resistant bacteria, people started to understand its potential
threat. Even though the primary threat was the dramatic increase in the emergence of bacterial
antibiotic resistance, the effect of the drug withdrawal was not negligible (Fey et al.,
2000;Hershberger et al., 2005). In poultry industry, the removal of AGPs from some commercial
farms increased disease incidences, especially those economically important diseases such as C.
perfringens induced NE and other enteric infections (Kumar et al., 2018). In Europe, studies show
that, with the removal of AGPs, disease incidence has dramatically increased. As a result,
antibiotics used in animal production as a treatment were elevated (Casewell, et al., 2003).
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Although strict biosafety practices without AGPs can maintain production in some farms (Engster
et al., 2002), it is difficult to rely on this approach for every farms. Therefore, AGPs alternatives
are much needed to control NE and other diseases.
Necrotic enteritis is caused by C. perfringens, which is a gram-positive, spore-forming, and nonmotile bacteria. C. perfringens is a normal inhabitant in the environment and in a healthy bird's
intestine (McDonel et al., 1980), and it is one of the fastest-growing pathogenic bacteria (Shimizu
et al., 2002). NE mostly occurs in broiler chicks between 2-6 weeks of age (Barnes et al., 1972).
Since C. perfringens cannot synthesize several essential amino acids, it releases enzymes that
degrade host tissue to meet its demand (Shimizu et al., 2002). In humans and animals, the ability
of C. perfringens to release toxins, to grow very fast in a wide range of temperatures, and to form
spores enable them to induce disease. C. perfringens induces NE by adhering to the small intestine
villi, multiplying and releasing toxins, which causes necrosis (Al-Sheikhly et al., 1977). Toxins
released by C. perfringens play a critical role in the incidence of NE. So far, more than 17 different
types of C. perfringens toxins have been studied (Losada-Eaton et al., 2008). Based on the types
of toxins released, C. perfringens is categorized into five types (A- E) (McDonel, 1980), such as
alpha (α), beta (β), epsilon (ε) and iota (ι) (Miclard et al., 2009). Out of all types of toxins, alpha
toxin is the only main toxin produced by all types of C. perfringens. Genes of C. perfringens toxins
can be found in both chromosomes and plasmids. The alpha-toxin is considered the first known
enzyme and main fatal bacterial toxin (Naylor et al., 1999). The alpha-toxin is an enzyme,
phospholipase C sphingomyelinase that damages the phospholipids of the cell membrane. Thus,
the alpha-toxin leads to the destruction of the cell membrane and the cell death by hemolysis or
necrosis (Naylor et al., 1999). Even though the alpha-toxin is responsible for myonecrosis of gas
gangrene, its effect on NE is controversial (Awad et al. 1995). C. perfringens types A and C have
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been the primary causative agents of NE. In type A strains, the alpha-toxin has phospholipase C
activity and plays a vital role in the pathogenesis of C. perfringens. Al-sheikhly et al. (1977)
induced NE by intro-duodenal infusions of C. perfringens crude toxins and broth culture into the
chickens' gut. Based on their findings, the alpha-toxin was the causative agent of NE (Al-sheikhly
et al., 1977). Infected chickens had shown higher alpha-toxin levels compared to uninfected
chickens (Hofshagen & Stenwig, 1992). Inoculation of germ-free chickens with either a broth
culture supernatant or a purified alpha-toxin of C. perfringens type A induced mortality and
intestinal lesions, whereas chickens challenged with an alpha-toxin and neutralized with an antialpha-toxin serum caused no deaths (Fukata et al., 1988). Birds with an NE history have shown a
significant level of alpha-toxin antibodies (Lovland et al. 2003). Though C. perfringens type A
strains are a normal inhabitant of the environment and healthy chicken gut, virulent strains produce
higher levels of alpha-toxin. Rehman et al. (2009) in their in vitro study determined that intestinal
mucosal barrier function was impaired by alpha-toxin (Rehman et al., 2009). However, since these
studies were based on crude or partially-purified toxins, the toxins can still have other co-purifying
proteins (Keyburn et al., 2006). Cooper & Songer (2009) have shown that creating NE lesions was
independent of the amount of in vitro alpha-toxin produced, even though immunization with
recombinant alpha-toxin provided partial protection against C. perfringens induced NE (Cooper
& Songer, 2009). Another in vitro study using C. perfringens isolated from healthy and NE
chickens showed no difference in alpha-toxin production (Gholami et al., 2006). Therefore, it
remains uncertain whether alpha-toxin is the main virulence factor of NE.
The pore-forming toxin NetB was thought an indispensable virulence factor in NE pathogenesis
(Keyburn et al., 2008). Keyburn et al. (2008) showed that NetB, not alpha-toxin, was responsible
for the incidence of NE. They found similar NE between the wild type strain and alpha-toxin
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negative mutants isolated from NE birds. In addition, in vitro experiment using LMH cells showed
that NetB toxin causes cell rounding and lysing. These results challenged the view that alpha-toxin
is a virulent factor in NE pathogenesis. NetB belongs to the alpha-haemolysin family of β-poreforming toxins, and it was isolated from the C. perfringens type A strain in NE birds. NetB toxininduced tissue damage may result in C. perfringens overgrowth (Cheung et al., 2010). In an
experimental NE model, NetB negative C. perfringens failed to induce NE (Timbermont et al.,
2011). Even though NetB has been reported as the main virulence factor for NE incidence, NetB
negative bacteria were also detected in NE birds (Chalmers et al., 2008).Therefore further studies
are much needed for investigating other C. perfringens virulence factors responsible for NE.
1.2 Predisposing factors: coccidiosis, nutrition and stress and immunosuppression
Coccidia is a protozoan parasite that propagates inside the host intestine and causes enteric disease.
So far seven species of Eimeria (E. maxima, E. acervulina, E. brunetti E. mitis, E. praecox, E.
necatrix, and E. tenella) have been known to infect birds (Williams et al., 2005). Eimeria species,
such as Eimeria maxima and Eimeria acervulina, are the most known predisposing factors for NE
in chickens (Al-Sheikhly et al., 1980). Even though coccidiosis and NE are associated and have
the similarity of their symptoms, coccidiosis is usually prior to or during the NE phase. The
Eimeria vaccine has been shown to increase the incidence of NE (Gholamiandehkordi et al., 2007).
As a result Eimeria species have been commonly used as a predisposing factor for experimental
reproduction of NE, either by administering a coccidia vaccine overdose or feeding live coccidia
to birds in order to induce intestinal damage (Pedersen et al., 2008). Destruction of the intestinal
lining by Eimeria may predispose the chickens to NE (Gazdzinski & Julian, 1992). Though there
is no clear mechanism showing how coccidia induces NE, possible causes are proposed. Damage
caused to the intestinal lumen, usually during coccidia propagation, leads to bleeding and thus the
5

leaked plasma proteins become a source of growth-substrate for C. perfringens (Van Immerseel et
al., 2004). Coccidiosis induced mucus production provides a suitable environment for C.
perfringens growth (Collier et al., 2008). C. perfringens is incapable of synthesizing many of the
essential amino acids (Shimizu et al., 2002). Genomic sequencing data shows that C. perfringens
cannot produce enzymes required for amino acid biosynthesis (Shimizu et al., 200;Drew al., 2004).
Diet play a very important role in the incidence of chicken NE (Drew et al., 2004). Diets high in
levels of indigestible, non-starch polysaccharides (NSP) feeds such as wheat, barley, rye and oats
have shown to be a predisposing factor for NE in birds (Kaldhusdal et al., 1999). In vitro, extracts
from wheat or barley has shown better bacterial growth compared to extracts from digested maize
(Annett et al., 2002). This may be associated with the presence of arabinoxylans and β-glucans,
which are not easily digested by the birds’ digestive system, however they can be used as a growthsubstrate for both the microbiota and pathogenic bacteria like C. perfringens (Annett et al., 2002).
On the other hand, NSP may create a very suitable environment for the bacteria by increasing
transit time and creating digesta viscosity (Choct et al,1999). Diets high in animal protein, such as
fish or meat/bone meal, has been shown to predispose birds to C. perfringens-induced NE
(Williams et al., 2005). In the experimental reproduction of NE, high concentration of fish meal is
commonly used as a predisposing factor for NE (Cowen, et al., 1987). In the lower part of the
intestine, poorly or not fully digested protein can act as a substrate for the gut microflora
(Timbermont et al., 2011). Fishmeal is a good source of zinc, glycine and methionine (Dahiya et
al., 2006), and glycine and methionine are known to stimulate C. perfringens growth in vitro
(Nakamura et al., 1968). Availability of zinc is linked with alpha-toxin production by C.
perfringens and can prevent trypsin from destroying the alpha-toxin (Baba et al. 1992). The gizzard
can be triggered by the presence of animal protein to increase the pH that favors C. perfringens

6

growth (Smith, 1965). Animal fat, such as tallow or lard, are believed to increase ileal C.
perfringens count more than plant oils (Knarreborg et al., 2002). Effects of anti-nutritional factors
such as protease inhibitors, lectins, and tannins may predispose birds to NE. Trypsin inhibitors
commonly found in soybean meal create a very suitable environment for bacterial growth by
leaving undigested proteins in the lower gut (Clarke & Wiseman, 2007). Lectins may enhance
bacterial adherence to the intestinal mucosa. Tannins can destroy intestinal tissue by strongly
acting with proteins (Robins & Brooker, 2005). In addition to the chemical nature of the feed, the
existence of gut microbes may depend on the physical nature of the feed (Smith & Macfarlane,
1998). Roller-mill ground wheat has been shown to minimize NE-induced death of chickens
compared to hammer ground wheat (Branton et al., 1987). Coarsely ground mash may initiate
HCL secretion and increase feed retention time in the gizzard and proventriculus (Engberg et al.,
2004)
Stress is considered another predisposing factor for NE, this could be due to the change in the gut
(McDevitt et al., 2006). Immunosuppressive diseases, such as Infectious Bursal Disease (IBD),
Chick Anemia Virus and Marek’s Disease, have been suggested to exacerbate the progress of C.
perfringens-induced NE (Lee et al., 2011). Experimentally reproduced NE using IBD vaccine as
a predisposing factor is evident (McReynolds et al., 2004). Chicken stressors like ammonia,
physiological stress, and high stocking density have been demonstrated to suppress the immunity
and to predispose chickens to NE (Tsiouris et al., 2015). They also showed the effect of
environmental stress like cold stress to cause immunosuppressive induced NE. Likewise,
Burkholder et al. (2008) reported that heat stress changes intestinal structure and disrupts
microbiota community (Burkholder et al., 2008).
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1.3. Alternative strategy for Necrotic enteritis
A probiotic is defined as “a live microbial food supplement that beneficially affects the host by
improving the intestinal microbial balance” (Fuller, 1999). Probiotics have been shown to play a
very important role in the host’s metabolism, immuno-stimulation, and disease protection (Edens,
2003). Probiotics can improve feed conversion efficiency, nutrient digestibility, and absorption by
modulating gut microbiota (Yeo & Kim, 1997), in addition, probiotics have been shown to prevent
different gastrointestinal (GI) diseases in animal production (La Ragione et al., 2004). Hence, they
have been one of candidates for an alternative strategy to antibiotics. They can be given via
drinking water, feed, or spray. Even though the mechanism of action is not very clear, some of the
possible mechanisms can be a direct action by competing with the pathogenic bacteria for nutrient
and niche establishment, or an indirect action by stimulating immune response and mucosal barrier
formation. Probiotics have also been shown to change enterocyte morphology by enlarging nuclei
and active impetus in cell mitosis (Kabir, 2009). Chichlowski et al. (2007) observed that probiotics
to enhance villus length and cell mitosis after adding B. subtilis to chicken feed (Chichlowski et
al., 2007). The most widely used probiotics for chickens are Bacillus, Aspergillus, Lactobacillus
Bifidiobacterium, Candida, and Sterptomyces (Apata, 2008). Lactobacillus and Bacillus are the
most widely used probiotics against C. perfringens-induced NE (Jadamus et al., 2001). Birds
supplemented with probiotics showed higher antibody titer compared to control birds (Haghighi
et al., 2006). They have also shown to prevent against bacterial infection by producing bacteriocins
(antibacterial activity) and inhibiting bacterial toxin production (Joerger, 2003). B. subtilis PB6
has been shown to protect birds from C. perfringens-induced NE and to improve gut health
(Jayaraman et al., 2013). B. licheniformis has been able to inhibit C. perfringens-induced NE in
broiler chickens (Knap et al.,2010).
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Vaccines are another candidate for an alternative strategy to control NE. Incidence of NE usually
occurs between birds aged 2-6 weeks; this might be due to the decline of maternal antibodies at
about 3 weeks of age (Ulmer-Franco et al., 2012). Comparing healthy birds with clinical NE birds,
healthy birds showed higher levels of antibodies (IgY) against both NetB and alpha toxin (Lee et
al., 2012). This observation suggests the importance of these antibodies on protecting against
necrotic enteritis. Several studies have been conducted on preventing NE using vaccines. Some of
them include inactivated toxins, live bacteria, DNA vaccines, and other proteins. These vaccines
have been administrated through feed, water, spraying on hatchery, and injecting in ova (Sharma,
1999). Despite reports of partial protection by these vaccines, there is still no effective commercial
vaccine against C. perfringens-induced NE.
1.4. Microbiota and its metabolites
Microbiota have been shown to prevent and treat different diseases. Microbiota transferred from
adult healthy birds to 2-day old birds have shown to protect against cecal colonization of
Salmonella infantis (Rantala & Nurmi, 1973). Humans GI diseases, such as recurrent C.
difficile infection, were successfully treated by microbiota transplantation (Anderso et al., 2012;
Lawley et al., 2012). Microbiota uses different mechanisms to prevent and treat diseases in
animals. One of them is competitive exclusion (CE). The term CE refers to that microbiota is
competing either for nutrient or physical attachment (colonization) with the pathogenic bacteria
physically or chemically. For example, Zinc is an important mineral for both the microbiota and
the pathogenic bacteria. Healthy beneficial microbiota prevents young chicks from pathogenic
bacterial colonization by competing for nutrients in the gut (Joerger et al., 2003; Schneitz et al.,
2005). Another CE mechanism is bacteriocin production. Bacteriocin secreted from the microbiota
has bactericidal property, hence it can be used for both prevention and treatment against pathogenic
9

bacteria (Caly et al., 2015). The gut microbiota play a crucial rule in the maturation and
development of the host digestive system including intestinal epithelium and immune system, and
this is mainly mediated by lymphoid organ development, antimicrobial peptide and
immunoglobulin A production, and lymphocyte activation and differentiation (Sommer &
Bäckhed, 2013). Forder et al. (2007) demonstrated the effect of microbiota on goblet cell and
mucosal cell architecture after hatching. Comparing with germ free animals, the conventionally
grown animals have been shown better development in intestinal morphology such as mucus layer,
epithelial layer, lamina propria, villi length and crypts depth (Deplancke & Gaskins, 2001;
Abrhams et al., 1963). In addition, the beneficial bacteria have been shown strong effects on the
intestinal T cells repertoire and cytokines expression (Mwangi et al., 2010).
Gut microbiota plays an important role in the growth and the performance of the animal. Even
though it is controversial whether microbiota penetrates the egg and inhabits the embryo before
hatch, many studies suggest the important effect of feed, water, hatching environment and
transportation on the microbiota profile and colonization in the post-hatch chickens (Kers et al.,
2018). Gut microbiota and their metabolic products improve nutrient digestion, absorption, and
metabolism as well as performance of the broiler chickens. This is believed to be mainly through
producing short chain fatty acid (SCFAs: acetate, propionate, butyrate, and lactate), amino acids,
and vitamins B and K (Ewing & Cole, 1994;Yadav & Jha, 2019). SCFAs are produced through
fermentation of indigestible non-starch polysaccharides and other polysaccharides; they provide
energy to the intestinal epithelial cell, increase villus height, and increase absorption (De Vadder
et al., 2014). This has been supported by the research using germ-free and conventional mice. The
germ-free mice have shown less villus thickness, intestinal surface area and impaired microvilli
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growth compared to the conventional mice (Deplancke & Gaskins, 2001). In addition, SCFAs have
also play a role in glucose regulation and energy and lipid metabolism (Den Besten et al., 2013).
1.5. Microbiota metabolites of bile acids in health and diseases
Bile acids are amphibiotic steroids synthesized from cholesterol in the liver by hepatocyte (Chiang
& Li, 2009). Because bile acids are more soluble in water than cholesterol, synthesizing bile acid
is the main route of cholesterol elimination from the body (Cohen, 2008). Bile consists of many
components such as bile salts, water, cholesterol, phospholipids, and bilirubin; however, bile acids
are the principal constituents of bile (Boyer, 2013). In addition to their importance in digestion of
dietary cholesterol, lipids, fat-soluble vitamins and other essential nutrients, bile acids also play a
vital role in their metabolism and regulation, transportation and control signaling events in liver
regeneration (Chiang, 2013). Bile acids are generally divided into primary and secondary bile
acids. Primary bile acids are cholic acid and chenodeoxycholic acid, and they are synthesized from
cholesterol by hepatocytes in the liver, and they are then further conjugated with two amino acids,
taurine or glycine, to become conjugated primary bile acids (Chiang, 2013). Conjugation increases
bile acid's water solubility and makes them physiologically efficient for fat digestion. Before they
are secreted to the duodenum via the bile duct, bile acids are stored in the gallbladder (Hundt &
Young, 2019). Bile acid secretion is triggered in response to cholecystokinin secreted from the
duodenum after food consumption. In response to this, the gallbladder contracts and releases bile
acids to the intestinal lumen (Hofmann, 1999). In human, about 95% of the released bile acids are
reabsorbed in the small intestine ileum and transported to the liver through enterohepatic
circulation (Dawson & Karpen, 2015). The remainder of the bile acids are excreted via feces (A F
Hofmann & Hagey, 2008; Ridlon et al., 2006). The excreted bile acids are replaced by synthesizing
new bile acids in the liver, and hence the total quantity of the bile salts is maintained.
11

Bile acid biosynthesis occurs via two pathways, the 'classical' and 'alternative' pathways (Chiang
& Li, 2009). The classical or neutral pathway occurs in the liver hepatocyte and represents the
majority of the primary bile acid synthesis. The classical pathway is initiated with the 7-α
hydroxylation of cholesterol by cholesterol 7-α hydroxylase (CYP7A1), and the next 12-α
hydroxylation is followed by multiple steps resulting in the synthesizing of the primary bile acids
chenodeoxycholic acid (CDCA) and cholic acid (CA) through the subsequent enzymatic action of
CYP8B1 and CYP27A1 (Thomas et al., 2008). Failure or reduction in bile acid synthesis through
the classical pathway is compensated by the alternative pathway (Pullinger et al., 2002). The
alternative pathway is initiated with the hydroxylation of the cholesterol side-chain by sterol 27
hydroxylase (CYP27A1) and produces CDCA via CYP7B outside the liver. The ratio of CDCA to
CA is determined by the expression of CYP8B (Chiang & Li, 2009). Gut microbiota deconjugates
and 7α-dehydroxylates the primary bile acids and converts them to secondary bile acids. They are
called secondary bile acids since they are formed due to the action of gut microbiota. Secondary
bile acids include deoxycholic acid (DCA), lithocholic acid (LCA) and ursodeoxycholic acid
(UDCA). CA and CDCA are converted to DCA and LCA, respectively (Devlin & Fischbach, 2015;
A F Hofmann & Hagey, 2008). Both conjugated and unconjugated bile acids are absorbed from
the intestine and return to the liver via hepatic portal circulation (Dawson & Karpen, 2015). After
returning to the liver, these bile acids inhibit new bile acid synthesis by suppressing the ratelimiting enzyme CYP7A1. Liver then conjugates the unconjugated bile acids and secrets them
again into the intestine via the bile duct (Gurantz et al., 1991).
In addition to their importance in lipid digestion and absorption, bile acids also play a critical role
as signaling molecules (ligands) in gene expression, lipid, and glucose metabolism and bile acid
synthesis through activating the bile acid receptors (Chiang, 2013). Bile acids are directly involved
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in their own synthesis through regulating gene expression (T. Li & Chiang, 2013). Bile acid
receptors farnesoid X receptor (FXR) and G-protein-coupled receptor-1 (GPBAR-1 or TGR5) are
found in the liver and intestine (Maruyama et al., 2002; Duboc et al., 2014). Farnesoid X receptors
(FXR) are nuclear receptors expressed at a high level in the liver and intestine (Makishima et al.,
1999; Schaap et al., 2014). CDCA is considered as a natural ligand for FXR. Bile acid production
is inhibited or activated based on the intestinal levels of bile acids. One of the main functions of
FXR activation is to suppress CYP7A1 in the hepatocyte (Gupta et al., 2001). When the intestinal
level of bile acids is high, a negative feedback pathway inhibits the production of new bile acids
(Heuman et al., 1989; Chiang, 2002).
In addition to their importance in host nutrition, metabolism, and immune homeostasis, gut
microbiota plays a vital role in the metabolism of bile acids (González-Regueiro et al., 2017).
Studies have shown that the population and composition of gut microbiota are affected by the
content and nature of bile acids (Kakiyama et al., 2013). Some of the most common human gut
microbiota involved in bile acids metabolism are Bacteroides, Bifidobacterium, Clostridium,
Lactobacillus, Eubacterium, and Escherichia (Elkins et al., 2001; B. V Jones et al., 2008). Rats
fed CA diet have shown to increase the phylum Firmicutes significantly and to reduce the
population of Bacteroidetes and Actinobacteria compared to the control group (Islam et al., 2011).
At the distal part of the intestine, gut microbiota converts primary bile acids, CA and CDCA, into
secondary bile acids of DCA, LCA and UDCA (Devlin & Fischbach, 2015; A F Hofmann &
Hagey, 2008). Primary bile acids undergo three main steps to be converted into secondary bile
acids: deconjugation, 7α-dehydroxylation, and 7α-dehydrogenation. Deconjugation of primary
bile acids is mediated by the enzyme bile salt hydrolase (BSH), and this leads to the cleavage of
the amino acid side chain taurine or glycine group (Ridlon et al., 2006). Deconjugation increases
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hydrophobicity and toxicity of bile acids to microbiota. Dehydroxylation (removal of OH group
to form 7-deoxy bile acids) is done by bacterial dehydratases of the anaerobic microbiota; hence
they convert CA to DCA (3α, 12α-dihydroxy-5β-cholanoic acid) and CDCA to LCA (3α-hydroxy5β-cholanoic acid (Monte et al., 2009; Gupta et al., 2001). In humans, this is mainly done by the
genus Clostridium (Buffie et al., 2015). UDCA is commonly found in less amounts in humans and
is synthesized by the action of hydroxyl steroid dehydrogenases (HSDHs) enzymes of the gut
microbiota after oxidation and epimerization of the 3-, 7- or 12-hydroxyl groups of bile acids.
Epimerization

is

a

reversible

process.

Clostridium,

Bacteroides,

Eubacterium,

Peptostreptococcus, and Escherichia coli are some of the enteric species that can undergo
oxidation and epimerization of hydroxy groups. These secondary bile acids have been shown to
modulate the gastrointestinal bacterial population; this is associated with the detergent property of
bile acids. Primary and secondary bile acids are considered as signaling molecules of (FXR) and
G-protein-coupled (GPBAR1) receptors, and together they are called bile acid-activated receptors
(BARs) (Maruyama et al., 2002; Duboc et al., 2014). BARs signaling has been shown to be
modulated by gut microbiota. In return, the bile acids also determine the composition and
population of gut microbiota. Even though the mechanism of how BSH protects the microbiota is
not fully studied (unconjugated bile acids are more hydrophobic and toxic), BSH enzymes
produced by the microbiota are considered as a mechanism for protection against the toxic effect
of bile salts (Begley et al., 2005). BSH hydrolyzed amino acids are suggested to have a nutritional
advantage for the bacteria (Begley et al., 2005). In vitro studies have shown that bile salts change
cell walls and cell membranes of Lactobacilli and Bifidobacteria. Deconjugation of primary bile
acids by BSH is the first step for 7a b dehydroxylation. Bacteria species belonging to Clostridia
are responsible for seven a b dehydroxylation (Wells et al., 2003). Intestinal microbiota plays a
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vital role in primary and secondary bile acids production and biotransformation through the FXR
receptor. In addition to the biotransformation to secondary bile acids, gut microbiota has also been
shown to inhibit bile acid production through alleviation FXR inhibition in the ileum (Sayin et al.,
2013).
In addition to their significant role in lipid digestion, metabolism, and signaling, bile acids have
been shown to treat both infectious and metabolic diseases (T. Li & Chiang, 2014). Mice with
obstructed bile ducts have shown proliferation and invasion of bacteria into the intestine, and this
action was recovered through oral administration of bile acids (Makishima et al., 2002). Dysbiosis
has been associated with infectious and metabolic diseases (Carding et al., 2015). Dysbiosis caused
by an alteration in secondary bile acids affects host glucose, lipid, and drug metabolism, suggesting
the potential use of bile acids as a therapeutic target for treating metabolic disease (Chiang & Li,
2009). Disruption of the bile acid profile induces inflammation and leads to the development of
the gastrointestinal disorders, such as C. difficile infection, irritable bowel syndrome, inflammatory
bowel diseases, and metabolic syndrome (Sartor, 2011; Schubert et al., 2014; Mayer, Savidge, &
Shulman, 2014). Hence modulation of gut microbiota and bile acid profiles can be an effective
therapeutic approach for the treatment of gastrointestinal diseases. Secondary bile acids have been
shown to prevent and treat against pathogenic microorganisms and other metabolic disorders. For
instance, UDCA is used in the treatment of cholesterol gallstones (Guarino et al., 2013). The Food
and Drug Administration (FDA) approved UDCA for the treatment of primary biliary cirrhosis
(Paumgartner, 2003). On the other hand, increasing the amount of secondary bile acids is
associated with colon cancer and cholesterol gall stones in human (Farhana et al., 2016)
C. difficile infection is one of the nosocomial infections in the US (Ananthakrishnan, 2011). C.
difficile is a Gram-positive, spore-forming and anaerobe bacterium. C. difficile vegetative induces
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inflammation and diarrhea by producing enterotoxins. Growth and germination of C. difficile have
been shown to be affected by the presence of bile acids. Primary bile acids taurine–conjugated CA,
taurocholic acid, has shown to induce germination of C. difficile; hence it is a normal ingredient
of C. difficile growth media (Wilson, 1983). Primary bile acid CDCA has been shown to inhibit
C. difficile spore germination (Sorg & Sonenshein, 2009; Sorg & Sonenshein, 2010 ;). On the other
hand, in vitro experiment has shown that secondary bile acid LCA and UDCA inhibit C. difficile
germination (Palmieri et al., 2018; Theriot et al., 2014). In vivo, antibiotic-treated mice have shown
a lower proportion of secondary bile acids and higher growth of C. difficile than untreated mice,
demonstrating the importance of secondary bile acids in inhibition and growth of C. difficile
(Theriot et al., 2014). The normal biotransformation of primary bile acid to secondary bile acid by
the gut microbiota was disrupted in patients with recurrent C. difficile infection. Recently, fecal
microbiota transplantation has been shown to successfully treat C. difficile infection by restoring
the normal composition of the gut microbiota. This transplanted microbiota has shown to restore
fecal bile acids by regulating gut microbiota (Weingarden et al., 2014).

16

1.6 Figure

Figure 1.

Figure 1.1 Flow chart demonstrates the structures of primary and secondary bile
acids with their synthetic pathways. The bile acid chemical structures were obtained
from https://en.wikipedia.org/wiki/Bile_acid and chart was then drawn based on this
report (Ridlon et al., 2006).
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Figure 1.

Chapter II:

Evaluation of Microbial Metabolic Product Deoxycholic Acid on Chicken Necrotic Enteritis
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2.1

Abstract

The reemerged necrotic enteritis (NE), caused by coccidiosis and C. perfringens infection, costs
$6 billion every year worldwide. Few effective antimicrobial alternatives are available to control
the disease. The objective of this study was to evaluate prevention and treatment of NE using
microbiota metabolic product secondary bile acid deoxycholic acid (DCA) in drinking water. Oneday-old birds were tagged and placed in floor pens. In experiments 1 and 2, the birds were infected
with Eimeria maxima at d 18 and C. perfringens at d 23 and 24 and the birds were euthanized at d
26. In experiment 3, the birds were infected with Eimeria at d 20 and C. perfringens at d 25 and
26 and euthanized at d 27. DCA was administrated in drinking water at 1.91, 0.95, or 0.48 mM.
Samples of small intestinal content and tissue were collected for isolating DNA, RNA or
histopathology. In experiments 1 and 3, birds experienced mild and severe body weight gain
(BWG) reduction respectively. Because of minimal body weight alteration in Em and NE birds
compared to non-infected birds in experiment 2, no tissue were collected for histopathology and
molecular biology assays. NE birds in experiment 1 developed mild NE of subclinical signs and
histopathology, while NE birds in experiment 3 suffered acute NE. Remarkably, 1.91 mM DCA
attenuated the BWG reduction in experiments 1 and 3. Consistently, DCA at drinking water
reduced NE-induced intestinal histopathology in birds of experiments 1 and 3. Mechanism studies
revealed that DCA reduced NE-induced expression of inflammatory gene Infγ in experiment 1.
Similarly, DCA reduced NE-associated C. perfringens luminal colonization elevation in
experiment 1. Using targeted metabolomics (LC-MS/MS) of bile acids, we found that NE is
associated with reduction of total bile acids in ileal content, an effect attenuated with DCA
supplementation in drinking water in experiment 1. In conclusion, microbial metabolic product
DCA in drinking water prevents NE-induced BWG reduction and histopathology, perhaps through
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reducing C. perfringens colonization and/or bile acid reduction. These findings may offer an
alternative strategy to use DCA for NE prevention and treatment.
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2.2 Introduction
Necrotic enteritis (NE) has reemerged as one of the prevalent intestinal diseases in the poultry
industry because of restricting usage of prophylactic antibiotics under consumer preferences and
regulatory pressures. It is estimated that NE costs $6 billion every year worldwide (Wade and
Keyburn, 2015). The main causative pathogens of NE are a spore-forming, anaerobic, and Grampositive bacterium Clostridium perfringens and coccidia Eimeria maxima or E. acervulina. Acute
NE by C. perfringens infection causes sudden death in birds of up to 50% mortality (Caly et al.,
2015). Subclinical NE is more common, and no obvious clinical signs are observed often without
peak mortality.
The withdrawing of antimicrobials in poultry production, however, is facing a number of
challenges, because antimicrobial free feeding regiments have affected the poultry industry by
elevated productivity loss and diseases, such as NE. Dissection of dead or severely ill NE birds
show that intestines are ballooned with gas, fragile and contain a foul-smelling brown fluid
(Timbermont et al., 2011). At the cellular level, intestinal tract of acute NE birds displays severe
small intestinal inflammation as infiltration of massive immune cells into lamina propria, villus
epithelial line necrosis, and crypt hyperplasia (Al-Sheikhly and Truscott, 1977; Long et al., 1974;
Wang et al., 2019). Progresses have been made toward understanding risk factors influencing the
outcome of NE such as C. perfringens virulence, coccidiosis, and feed (Prescott et al., 2016).
However, it remains largely unresolved on NE pathogenesis, and little progress has been made on
the strategies of antibiotic alternatives to prevent and treat NE.
C. perfringens colonizes in the intestinal tract among normal chicken microbiota. The presence of
a high dose of C. perfringens in the intestine does not sufficiently induce NE and its count alone
does not associate with NE (Craven, 2000; Kaldhusdal et al., 1999; Pedersen et al., 2003).
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Pathogenic C. perfringens is thought to drive the development of NE with various toxins. Different
strains of C. perfringens produce a variety of toxins such as alpha (CPA, type A), enterotoxin
(CPE), necrotic enteritis B-like toxin (NetB), and others (Navarro et al., 2018). Among them, C.
perfringens isolated from NE birds are mainly type A strains. Researchers in Australia have
reported that NetB but not CPA induced NE in chickens (Keyburn et al., 2008). However, NE does
not have strong association with NetB positive C. perfringens in the United States (Martin and
Smyth, 2009).
Microbiota composition is altered in NE birds compared to healthy birds (Antonissen et al., 2016).
The human and animal intestine harbors up to trillions of microbes, and this intestinal microbiota
regulates various host functions such as the intestinal barrier, nutrition and immune homeostasis
(Belkaid and Hand, 2014; Caricilli et al., 2014; Subramanian et al., 2014; Sun and Jia, 2018). At
the gut level, microbiota transplantation has shown tremendous success against recurrent
Clostridium difficile infection (Silverman et al., 2010). The production of secondary bile acids by
C. scindens is found to inhibit C. difficile colonization and infection (Buffie et al., 2015). Bile acids
synthesized and conjugated in the liver, such as tauro- or glycol-cholic acids (TCA or GCA) and
tauro- or glycol-chenodeoxycholic acids (TCDCA or GCDCA), are metabolized in the intestine
by the gut microbiota through deconjugating (e.g. CA or CDCA). They are then transformed into
secondary bile acids, such as deoxycholic acid (DCA), lithocholic acid (LCA), or ursodeoxycholic
acid (UDCA) (Ridlon et al., 2006). Majority of bile acids (>95%) are effectively absorbed in the
intestine (Ridlon et al., 2006). Bile acids have been reported in association with a variety of chronic
diseases (Bernstein et al., 2011; Ma and Patti, 2014), but new evidences shed light on the beneficial
property of secondary bile acids in health and diseases, such as gut motility (Yano et al., 2015),
and C. difficile infection (Buffie et al., 2015).
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Anaerobic microbiota and its metabolite DCA prevent Campylobacter jejuni-induced intestinal
inflammation (Sun et al., 2018) in mice and the bacterial colonization in chickens (Alrubaye et al.,
2019). More recently, we found that DCA supplemented in feed prevented NE-induced acute
intestinal inflammation and body weight gain reduction (Wang et al., 2019). In the study,
decreased feed intake in NE birds posed an obstacle to effectively delivering sufficient dietary
DCA to the birds. To address this issue, in these current experiments, different doses of DCA in
drinking water were used to prevent and treat subclinical and acute NE. The results from this study
will help the understanding of NE pathogenesis and assist in developing new antimicrobial
alternatives against NE.
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2.3 Material and method
Chicken experiments
All the experiments were approved by the Institutional Animal Care and Use Committee (IACUC)
of the University of Arkansas. The experiments were conducted at JKS Poultry Health Laboratory
at University of Arkansas at Fayetteville. Day old broiler chicks were obtained from CobbVantress (Siloam Springs, AR). They were received, neck-tagged and randomly assigned to floor
pens in an environmentally-controlled house. No medication was added to the feed. Feed and water
were supplemented ad libitum and temperature was maintained according to their age, 34°C for
the first 5 days and then gradually decreased to 23°C until the final day 26 or 27. The broiler chicks
were fed a corn-soybean meal-based starter diet for the first 0-10 days of age and a grower diet
during 11-27 days of age. Because gross necrotic lesion was often observed in upper ileum in this
NE model, the ileal tissue and digesta samples from all sacrificed birds were collected for RNA
and DNA analysis. Below were the three separated chicken experiments.
Experiment 1
Day old birds were placed in 4 floor pens with 16 birds per pen. DCA at 1.91 mM was
administrated in drinking water from d 16 to 26 as a prevention approach. The birds were then
gavaged with 20,000 sporulated oocytes/bird E. maxima at d 18 as described before (Wang et al.,
2019). An aliquot of frozen C. perfringens was cultured in TSB and sodium thioglycolate
overnight for the NE challenge study, and it was serially diluted and plated on tryptic soy agar plus
sodium thioglycolate for enumerating colony forming unit (CFU). The broiler birds were gavaged
with 109 CFU/bird C. perfringens at d 23 and 24 as described before (Wang et al., 2019). Chicken
body weight was individually measured at d 0, 18, 23, and 26. Bird health status was monitored
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daily after the pathogen infection. Six birds with average BW of each group were sacrificed at d
23 and 26. Intestinal tissues were collected for histopathological analysis from proximal ileal tissue
of about 10 cm, starting close to Meckel’s diverticulum. The samples then were flushed with PBS
buffer (pH 7.6) and then excised longitudinally and then positioned the mucosa side up on the
small pieces of blotting paper. The intestinal tissue was then Swiss rolled and fixed in 10% buffed
formalin solution, later dehydrated and embedded in paraffin for histological processing.
Experiment 2
Day-old birds were placed in 6 floor pens with 16 birds per pen. DCA at 1.91 mM was
administrated in drinking from d 16 (NE prevention 1 (prev1)), 20 (NE prevention 2 (prev2)), and
23 (NE treatment (trt)). The birds were infected with E. maxima and C. perfringens as described
above. The birds were individually weighted at d 0, 18, 23, and 26 as described above. Bird health
status was monitored daily after the pathogen infection. Because minimal body weight alteration
in Em and NE birds compared to noninfected birds, no tissue were collected for histopathology
and molecular biology assays.
Experiment 3
Day-old birds were placed in 7 groups (2 floor pens/group and 16 birds/pen). DCA was
administered in drinking water at 1.91, 0.95 or 0.48 mM from d 17 (prev), or 1.91 mM at d 25 (NE
trt). Coccidiosis vaccine was purchased from Huvepharma, (ADVENT) and the vaccine contains
live oocysts of E. acervulina, E. maxima and E. tenella. Broiler chicks were challenged with E.
maxima, E. acervulena and E. tenella at 60,000, 58,000 and 17,500 sporulated oocysts/bird,
respectively, at d 20 to induce coccidiosis. Then the birds were gavaged with 10 9 CFU/bird C.
perfringens at d 25 and 26 as described above. Individual chicken body weight was measured at d
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0, 20, 25, and 27. The bird health status was monitored daily after the pathogen infection. Five
birds with representative BW of each group were sacrificed at d 25 and 27. Intestinal tissues were
collected for histopathological analysis from the proximal ileal tissue as described above.
Histopathology evaluation
Intestinal Swiss-Rolled samples were processed at the Histology Laboratory in the Department of
Poultry Science at the University of Arkansas at Fayetteville. Briefly, the tissue was dehydrated and
embedded in paraffin. The section was cut at 5 μm thick using a rotary microtome. The slide was
then stained with standard Hematoxylin and Eosin (H&E) to determine for histological
morphology. Photographs were acquired using a Nikon TS2 fluorescent Microscope system. Ileal
inflammation was scored as described before (Wang et al., 2019). Briefly, each Swiss-Rolled slide
was divided into 4 areas and scored. Total histopathological scores were then calculated by adding
the 4 area scores. The following score scales were used as described before (Wang et al., 2019).
Briefly, score 0: no inflammation and villi and crypt intact; score 1: small number infiltration cells
in laminar propria of villi and crypts or villi minimally shortened; score 2: more extensive
infiltration cells in laminar propria of villi and crypts, villi shortened >¼ and edema, or crypt
hyperplasia; score 3: pronounced infiltration cells in laminar propria of villi, crypts, submucosa,
and muscularis, villi shortened >½ and edema, or crypt hyperplasia and regeneration; and score 4:
necrosis, villus diffuse, ulcers, crypt abscesses, or transmural inflammation (may extend to serosa).
Real time RT-PCR of mRNA gene expression and C. perfringens quantification
Total RNA from ileal tissue was extracted using TRIzol as described before (Wang et al., 2019).
cDNA was prepared using M-MLV (NE Biolab). mRNA levels of proinflammatory genes were
determined using SYBR Green PCR master mix (Bio-Rad) on a Bio-Rad 384-well Real-Time PCR
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system and normalized to Gapdh. To quantify C. perfringens intestinal luminal colonization or
tissue invasion, ileal digesta or tissue were weighed, bead-beated, and extracted for DNA using a
phenol-chloroform method as described before (Wang et al., 2019). C. perfringens in the digesta
and tissue was quantified using specific C. perfringens 16S rDNA primers by the qPCR. The PCR
reactions were performed according to the manufacturer’s recommendation. The following gene
primers were used:
Cp16S_forward: 5’- CAACTTGGGTGCTGCATTCC-3’; Cp16S reverse: 5’GCCTCAGCGTCAGTTACAG-3’; Mmp9_forward: 5’-CCAAGATGTGCTCACCAAGA3’; Mmp9_reverse: 5’-CCAATGCCCAACTTCTCAAT-3’; Litaf _forward: 5’AGATGGGAAGGGAATGAACC; Litaf _reverse: 5’-GACGTGTCACGATCATCTGG3’; Il1β_forward: 5’-GCATCAAGGGCTACAAGCTC-3’;
Il1 β_reverse: 5’-CAGGCGGTAGAAGATGAAGC-3’; Infγ_forward: 5’AGCCGCACATCAAACACATA -3’; Infγ_reverse: 5’- CCAGGTTGCTGCTCTACTCC3’; Gapdh_forward: 5’-GACGTGCAGCAGGAACACTA-3’; Gapdh_reverse: 5’CTTGGACTTTGCCAGAGAGG-3’. Gene expression of fold change was calculated using ΔΔCt
method and Gapdh as internal control.
Quantification of ileal bile acids using targeted metabolomics
In experiment 1, the ileal digesta was collected and the bile acid composition was analyzed using
multiple reaction monitoring (MRM) mass spectrometry in the Statewide Mass Spectrometry
Facility at the University of Arkansas at Fayetteville. Intestinal bile acids were extracted using
chloroform/methanol. To identify and quantify bile acids, MRM methods have been developed for
tauro- and glyco-cholic acid (TCA/GCA), tauro- and glyco-chenodeoxycholic acid
(TCDCA/GCDCA), cholic acid (CA), chenodeoxycholic (CDCA), deoxycholic acid (DCA),
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lithocholic acid (LCA), ursodeoxycholic acid (UDCA) isotopically labeled (some were with
deuteriums and some were with five deuteriums) and unlabeled standards. The methods were fully
optimized using data acquisition software attached to Shimadzu UPLC-20A/LC-30A coupled with
Shimadzu 8050 triple quadrupole mass spectrometer at their respective retention times. Once the
methods were optimized, the samples with isotopically labeled internal standards were analyzed
along with standards with varying concentrations. Calibration curves with internal standards were
used to estimate bile acid concentration. Use of internal standard accounts for sample loss during
the extraction procedure. LC-MS/MS analysis was performed in negative-ion mode. Methodology
is quite similar to what has been described before (Diaz Perez et al., 2019). LC separation was
performed using a C18 column. The flow rate was 0.3 mL/min and sample volumes of 1µL were
injected. The three most intense multiple reaction monitoring (MRM) fragments for each bile acid
standard were first fully optimized at their respective retention time windows using Shimadzu Lab
solution software as described before. From the three MRM channels, the MRM event
corresponding to the most intense fragment ion was used as the “quant” ion and the other two
fragment ions were used as reference ions for identification purposes. Reference ion ratios were
calculated compared to the “quant” ion, and unknown samples were required to meet within 30%
of the reference ion ratio of the standard.
Statistical Analysis
Data were first analyzed by One-way ANOVA for significant difference and then t-test using
Prism 7.0 software. Experiments were considered statistically significant if P values were < 0.05.
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2.4 Results
DCA reduced NE-induced body weight gain reduction
In experiment 1, the birds infected with E. maxima and C. perfringens showed subclinical NE
signs with mild diarrhea and no mortality. There was no difference in daily body weight gain
(BWG) between groups of birds during the uninfected phase from d 0 to 18 and during the E.
maxima infection phase (Em) from d 18 to 23 (Figure 2.1). During necrotic enteritis phase (NE)
from d 23 to 26, NE birds showed 26% BWG reduction (76 vs. 56 g/day/bird, P = 0.03) compared
to uninfected birds. Notably, DCA at 1.91 mM in drinking water trended to restore the BWG
reduction compared to NE birds (71 vs. 56 g/day/bird, P = 0.07).
To validate these results of drinkable DCA against NE, we ran experiment 2 with 6 groups of
uninfected, Em, NE, NE+ DCA 1.91 mM from d 16 (NE prevention 1 (prev1)), NE+ DCA 1.91
mM from d 20 (NE prevention 2 (prev2)), and NE+ DCA 1.91mM from d 23 (NE treatment (trt)).
The NE birds did not show any clinical signs of NE. Consistent with the weak clinical signs, body
weight gain between the groups were not significant (Figure 2.2). The minimal NE disease in this
experiment might be due to the inability of E. maxima to induce coccidiosis.
Next, to repeat the results of drinkable DCA against NE, we ran experiment 3 with 7 duplicated
groups of uninfected, Em, NE, NE+ DCA 0.48 mM from d 16 (DCA prevention low), NE+ DCA
0.95 mM from d 16 (DCA prevention medium), NE+ DCA 1.91 mM from d 17 (DCA prevention
high) and NE+ DCA 1.91 mM from d 23 (NE trt). Consistently, BWG between groups of birds
was not different before infection from d 0 to 20 (Figure 2.3). In contrast with experiments 1 and
2, the birds in this experiment were challenged with higher doses of a mixture of E. aceralina, E.
maxima, and E. tenella. As a result, the high dose of coccidia infection induced strong coccidiosis
with severe watery diarrhea, morbidity of birds, and body weight gain reduction (Figure 2.4).
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Specifically, at Em phase of d 20 to 25, coccidia-infected birds lost more than 41% of BWG
compared to non-infected birds (36 vs. 61 g/day/bird, P= 0.0001), while DCA prevention and
treatment failed to improve BWG. At the NE phase from d 25 to 27, NE birds severely lost BWG
compared to non-infected birds (-7 vs. 67 g/day/bird, P=0.0001). Notably, DCA high dose
(prevention) of 1.91 mM in drinking water was able to recover the BWG (26 vs. -7 g/day/bird, P=
0.0136). Together, these results suggest that the high dose of 1.91 mM DCA as a prevention
approach is able to increase BWG in subclinical and acute NE.
DCA alleviated the NE-induced intestinal inflammation
To evaluate how NE and DCA impact BWG, we then sought to examine the underlying
histopathological alteration. The ileal tissues were collected and H&E histology slides were
prepared. In experiment 1 of subclinical NE, upon the examination of the histopathology, the small
intestine of NE birds showed intestinal inflammation such as shortening of villi, hyperplasia of
crypt, and infiltration of inflammatory cells into the intestinal lamina propria comparing with
uninfected birds. Remarkably, DCA at 1.91 mM in drinking water reduced the histopathological
lesions and scores (7.2 vs 12, P=0.0173) compared to NE birds (Figure 2.5A and B).
To further evaluate the effect of DCA against acute NE, histology slides in experiment 3 were
prepared. Consistent with the previous report (Wang et al., 2019), the Em birds showed intestinal
inflammation and NE birds extended the inflammation, an effect attenuated by 1.91 mM DCA in
drinking water as a prevention (Figure 2.6A). As a result, NE birds with a high dose of DCA in
drinking water showed reduced histopathological scores (Figure 2.6 B) compared to NE birds (7.2
vs 16, P=0.0073). Interestingly, DCA prevention at 0.48 and 0.95 mM or DCA treatment at 1.91
mM reduced histopathological lesions and scores to a lesser extent. Together, the results suggest
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that DCA at a high dose (prevention) in drinking water was able to prevent subclinical and acute
NE-induced intestinal inflammation.
DCA alleviated inflammatory mediators
Inflammation is an important pathological feature of necrosis (Zitvogel L, 2010); we next
evaluated the role of DCA on host inflammatory responses. We evaluated the expression of
proinflammatory mediator genes in chicken ileal tissue in experiment 1 of subclinical NE using
Real-Time PCR. mRNA in ileal tissue was isolated and cDNA was prepared. mRNA levels of
proinflammatory genes of Infγ, Litaf (Tnfα), and Il1β were determined using SYBR Green PCR
master mix system and normalized to Gapdh. Interestingly, NE induced proinflammatory gene
Infγ mRNA accumulation by 4 folds compared to that in uninfected birds (Figure 2.7). Importantly,
DCA reduced the inflammatory mediator gene expression by 75 % compared to that in NE birds.
DCA reduced C. perfringens luminal colonization in small intestine
The reduction of inflammatory response by DCA in drinking water could be attributed to less C.
perfringens

colonization

in

ileum.

To

examine

this

possibility,

we

measured C.

perfringens intestinal luminal colonization in ileal lumen. The ileal digesta were weighed, beadbeated, and extracted for DNA using a phenol-chloroform method as described before (Wang et
al., 2019). C. perfringens in the digesta was quantified using real time PCR targeting specific C.
perfringens 16S rDNA primers (Wang et al., 2019). Interestingly, NE increased C. perfringens
luminal colonization by 2 logs compared to noninfected birds (Figure 2.8). Remarkably, DCA
significantly reduced C. perfringens luminal colonization in the small intestine compared to NE
birds.
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DCA restored NE-induced bile acid reduction in ileum
Bile acids are important host-derived microbial metabolites and play an essential role in health and
diseases (Sun and Jia, 2018). Limited knowledge is available on how intestinal bile acids are
changed during NE. We reasoned that DCA in drinking water might influence the status of the
ileal bile acid pool. To address this possibility, we performed targeted metabolomics on 9 bile
acids using ileal content samples in experiment 1. Notably, NE strongly reduced total bile acid
levels (7000 vs. 2000 nmol/g digesta, P= 0.0127) (Figure 2.9A). Remarkably, DCA in drinking
water increased the total bile acid level to 5000 nmol/g. Furthermore, DCA in drinking water
modified bile acid composition. As showed in Figure 2.9B, DCA in drinking water increased DCA
proportion from 0.1 to 51% in the expense of TCDA (from 42 to 34%), CDCA (from34 to 5% ),
TCA (from 15 to 6 %), and CA (from 6 to 1.5%). These results suggest that NE reduces ileal bile
acid pool and DCA is able to restore the bile acid pool reduction.
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2.5 Discussion
We previously reported that DCA supplemented in feed reduces acute NE (Wang et al., 2019). In
that experiment, the reduced feed intake in both NE and DCA-fed chickens raised the concern of
the effectiveness of dietary delivery of DCA. To address this issue, we conducted three follow-up
experiments to use alternative delivery approach of DCA in drinking water. We also investigated
the possibility to treat NE using drinkable DCA in water. Interestingly, the birds in the current
study experienced three levels of NE from none, subclinical, to acute ileitis, in association with
increased severity of coccidiosis respectively. Importantly, DCA at 1.91mM drinking water
prevented both subclinical and acute NE, showing attenuated body weight gain reduction and
intestinal inflammation. DCA with lower doses, or as treatment, failed to reduce NE and body
weight gain reduction.
One of the interesting observations in this study was that NE outcome was exclusively dependent
on coccidiosis severity. It is well known that NE outbreak is dependent on various predisposed
factors such as coccidiosis, feed, and C. perfringens virulence. Various C. perfringens strains
produce a number of toxins such as alpha (CPA), beta (CPB), epsilon (ETX), iota (ITX),
enterotoxin (CPE), necrotic enteritis B-like toxin (NetB), and others (Navarro et al., 2018). Among
them, it is reported that NetB but not CPA induces NE in chickens (Keyburn et al., 2008).
However, NE has not been strongly associated with NetB positive C. perfringens in the United
States (Martin and Smyth, 2009). In our experiment 1, because of the old E. maxima, the birds
experienced weak coccidiosis, showing mild clinical signs and body weight gain reduction. As a
result, the following NE was subclinical on clinical signs, body weight gain reduction, intestinal
histopathology, and inflammation. Consistently, in the second experiment, no coccidiosis and no
subsequent NE were present at all because of the even older E. maxima. In contrast, in the third
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experiment, we used fresh and higher doses of a mixture of E. acerulina, E. maxima, and E. tenella.
As expected, severe coccidiosis was present, and the birds showed profuse watery diarrhea and
severe body weight gain reduction. Consequently, the followed NE was severe. In all three
experiments, we used the same dose of the same NetB positive C. perfringens, whereas the
outcome of NE was strikingly different only because of the coccidiosis severity variations. Based
on these results, it is apparent that coccidiosis severity is indispensable for the successful
development of subsequent NE.
Although DCA at 1.5 g/kg diet was able to effectively prevent acute NE (Wang et al., 2019),
improvement is needed to reduce cost and to increase treatment efficiency. The higher DCA dose
of 1.91mM in drinking water is approximately similar to the 1.5 g/kg diet when feed intake and
water consumption has a ratio of 1 to 2 (Pesti et al., 1985). The advantage of water delivery is the
ease and quickness to administrate DCA at farms. In addition, we observed that water consumption
of NE birds was reduced less compared to feed intake. Consistent with the previous report (Wang
et al., 2019), high doses of DCA at 1.91m M drinking water was able to prevent both subclinical
and acute NE. In addition, high doses of DCA at 1.91mM drinking water reduced C. perfringens
intestinal colonization in subclinical NE birds. DCA reduces C. perfringens in vitro growth (Wang
et al., 2019) and the reduction of NE and C. perfringens in NE birds was expected. The high dose
of DCA in drinking water as prevention approach was administrated just before coccidia infection
(d 16 or 18), while dietary DCA in the previous study was started from d 0. Both of these
approaches are effective against NE and it is therefore possible to supplement DCA into the diet
at later age.
It is puzzling that the medium (0.95 mM) and lower doses (0.47mM) of DCA as prevention failed
to reduce acute NE. It was observed (data collection not successful) that those birds consumed
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more water compared to birds with high dose DCA during NE, suggesting comparable total DCA
intake between groups. This indicates that a minimal threshold concentration of DCA in drinking
water is needed to effectively prevent NE. Another unexpected result is that the high dose of DCA
as a treatment approach did not reduce acute NE. This result suggests that DCA takes a longer
time to reduce NE possibly either to attenuate coccidiosis or to accumulate sufficient DCA in the
enterohepatic circulation/cycle. Since bile acids as a treatment and prevention against disease is
new, further research is much needed.
Furthermore, subclinical NE birds apparently had 67% less total bile acids in ileal content
compared to that of uninfected birds, whereas the NE birds had 26% less body weight gain
reduction compared to the uninfected birds. Patients with inflammatory bowel disease, especially
those infected at the distal part of the ileum, often show bile acid malabsorption (Gothe et al.,
2014;Vitek, 2015). Interestingly, the expression of the apical sodium/BA cotransporting
polypeptide is responsible for ileal BA reabsorption and is reduced in ileal biopsies from patients
with Crohn’s Disease free of any signs of inflammation (Jung et al., 2004). Although the birds in
experiment 1 had a subclinical NE with no severe obvious diarrhea present, the loss of bile acids
in excrete from the enterohepatic cycle in the birds might be one of the factors. Importantly, in
experiment 1, DCA in drinking water was able to compensate for the loss of the total bile acid
reduction, in association with reduced NE on body weight loss, intestinal histopathology, and
inflammation. It remains unclear whether the protection from drinkable DCA comes from actions
to specifically antagonize C. perfringens or just to restore total intestinal bile acid pool. Following
up research is needed to clarify the underlying mechanism.
In conclusion, these data indicate that DCA in drinking water was able to prevent subclinical and
acute NE, possibly through restoring the intestinal bile acid pool and reducing C. perfringens ileal
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colonization. The finding from this study pinpoints the need to understand the bile acid metabolism
in intestinal health and diseases. These discoveries could be applied to control NE and other
intestinal diseases targeting the microbiome and host metabolism.
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2.6 Figures

Figure 2.1
DCA reduced subclinical NE-induced body weight gain (BWG) reduction in
experiment 1.
Cohort of one-day-old broiler chicks were individually tagged and placed in three floor pens (16
birds/pen). DCA at 1.91 mM was administrated in drinking water from d 16 to 26 as prevention.
The chickens were gavaged with 20,000 sporulated oocytes/bird E. maxima at d 18 and 109
CFU/bird C. perfringens at d 23 and 24. Bird BWG was measured at d 18 (16 birds/group), 23 (11
birds/group), and 26 (8–9 birds/group). Six birds with representative BW in each group were
euthanized at d 26. All graphs depict mean ± SEM. *P < 0.05; **P < 0.01.
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Figure 2.2

Bird BWG in experiment 2.

Cohort of day-old broiler chicks were individually tagged and placed in six floor pens (16
birds/pen). DCA at 1.91 mM was administrated in drinking water from d 16 to 26 (NE prevention
(prev1)), d 20 to 26 (NE prev2), or d 23-26 (NE treatment (trt)). The birds were infected with E.
maxima and C. perfringens as described in Figure 2.1. Bird BWG was measured at 18 (16
birds/group) and 26 (8–9 birds/group) days of age. All graphs depict mean ± SEM.
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Figure 2.3

Bird BWG during d 0-20 in experiment 3.

Cohort of day-old broiler chicks were individually tagged and placed in fourteen floor pens (2
pens/group and 16 birds/pen). DCA was administrated in drinking water from d 17 to 27 as
prevention at 0.48, 0.95, or 1.91 mM, or as treatment from d 25 to 27 at 1.91 mM. Broiler chicks
were challenged with E. maxima, E. acervulena and E. tenella (60,000, 58,000 and 17,500
sporulated oocysts/bird, respectively) at d 20. The birds were gavaged with 10 9 CFU/bird C.
perfringens at d 25 and 26. Body weight gain was measured at d 0, 20, 25, and 27. Five birds with
representative BW of pen were euthanized at d 27. All graphs depict mean ± SEM.

51

Figure 2.4

DCA attenuated acute NE-induced BWG lost during d 20-27 in experiment 3.

Birds were raised and infected as in Figure 2.3. Shown is BWG during d 20 to 25 (coccidiosis
phage) and d 25 to 27 (NE phase). All graphs depict mean ± SEM. *P < 0.05.
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Figure 2.5

DCA attenuates subclinical NE-induced intestinal inflammation in experiment 1.

Birds were raised and infected as in Figure 2.1. Small intestine sample was collected, stained with
H&E, and evaluated with histopathological scores. (A) H&E staining showing representative
intestinal histology images. (B) Quantification of histological intestinal damage score. All graphs
depict mean ± SEM. Scale bar represents 200 μM. *P < 0.05.
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Figure 2.6

DCA attenuates acute NE-induced intestinal inflammation in experiment 3.

Birds were raised and infected as in Figure 2.3. Small intestine sample was collected, stained with
H&E, and evaluated with histopathological scores. (A) H&E staining showing representative
intestinal histology images. (B) Quantification of histological intestinal damage score. All graphs
depict mean ± SEM. Scale bar represents 200 μM. *P < 0.05.
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Figure 2.7

DCA reduced NE-induced inflammatory gene expression.

Birds were raised and infected as in Figure 2.1. Small intestine sample was collected for RNA
extraction. Inflammatory gene expression of Infγ, Litaf (Tnfα), and Il1β was quantified with real
time PCR and normalized to Gapdh. All graphs depict mean ± SEM. *P < 0.05.
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Figure 2.8

DCA reduced NE associated increased C. perfringens luminal colonization.

Birds were raised and infected as in Figure 2.1. The intestinal content/digesta was collected for
DNA extraction. Luminal C. perfringens colonization level quantified by 16 S rDNA real-time
PCR. All graphs depict mean ± SEM. *P < 0.05.
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Figure 2.9

DCA reduced NE-induced bile acid reduction.

Birds were raised and infected as in Figure 2.1. Ileal digesta was collected and the bile acids
composition was analyzed using targeted metabolomic analysis (LC-MS/MS). (A) Total bile acid
quantification in ileum. (B) Relative percentage of bile acids in ileum content. All graphs depict
mean ± SEM. *P < 0.05.
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Chapter III:
Evaluation of Reconstituting Chicken Microbiota on Broiler Chicken Growth Performance
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3.1 Abstract
Industrialization of the agricultural field has fundamentally changed the production practices and
the environment within which animals interact. Antimicrobial overuse associated with animal
industrialized production is a partial cause of antimicrobial resistance. It is urgent to find
antimicrobial free alternatives as growth promoters in the poultry industry, but few effective
antimicrobial alternatives are currently available. The objective of this study was to modulate
chicken microbiota on the bird growth performance. Mouse specific pathogen free (SPF) stool was
cultured on Brain Heart Infusion (BHI) agar under anaerobic or aerobic conditions and collected
as SPF anaerobic microbiota (SPF-Anaero) and aerobic microbiota (SPF-Aero). Day-old birds
were tagged, weighed and randomly assigned to 9 pens. The birds were orally gavaged with PBS,
108 CFU/bird SPF-Anaero, or 108 CFU/bird SPF-Aero. The bird weight was measured at d 0, 14,
and d 28. The broiler chickens were euthanized at d 28. Body weight gain was analyzed using oneway ANOVA followed by t-test. Interestingly, birds colonized with SPF-Anaero grew 15%
heavier during the starter period of d 0-14 (28 vs. 24 g/day/bird, P= 0.0009) compared to control
birds without microbiota colonization, while birds colonized with SPF-Aero gained 8% more body
weight compared to control birds (26 vs. 24 g/day/bird, P= 0.02). Consistently, SPF-Anaero birds
grew faster compared to control birds during d14-28 (67 vs. 60 g/day/bird, P= 0.007). As a result,
SPF-Anaero and SPF-Aero birds grew 15 and 4%, respectively, heavier on accumulative body
weight gain compared to control birds (47 vs. 42 g/day/bird, P= 0.0009; 44 vs. 42 g/day/bird, P=
0.03, respectively). In conclusion, microbiota as an antimicrobial free alternative is able to improve
bird body weight gain. Specific members of the microbiota could be identified, isolated and
applied in the poultry industry.
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3.2

Introduction

Approaches in agricultural production such as raising poultry have changed for the past 10,000
years, with increasing speed and influence over the recent centuries (Godfray et al., 2010). The
speed of agricultural transition to an industrialization system has accelerated and deepened since
the 19th century, and industrialized production of food animals began in the poultry sector in the
United States in the 1920s (States, 2020). Like wild birds, chicken hens have laid and hatched eggs
and raised their chicks in some area of modern countryside and in pre-industrialization era. During
the industrialization transition of massive poultry production, eggs laid by hens were hatched in a
hatchery and the chicks were raised apart from their parents. In this practice, the loss of microbiota
transmission from parents to offspring chickens are apparent and the consequence is being
recognized in the era of growing microbiome research.
Poultry meat from chickens or turkeys, is the most consumed animal protein (States, 2020).
Antibiotic growth promoters (AGPs) have been widely used in the poultry industry as a growth
promoter and disease prevention for decades (Lin, 2014). However, with restricting AGPs by the
European Union (EU) in 2006 in association with consumers’ demand and pressure around the
world, rearing chickens without AGPs has experienced a variety of challenges (Engster et al.,
2002). In addition to the decreasing the overall performance of the birds after withdrawing AGPs
(Engster et al., 2002), enteric diseases such as Clostridium perfringens induced necrotic enteritis
and others enteric diseases have also emerged (M'Sadeq et al., 2015). Active research has been
undertaken for cost effective alternatives to AGPs. Microbial products and individual or groups of
bacteria have been reported to be effective, such as short chain fatty acid butyrate and probiotics,
at some degree (Bortoluzzi et al., 2017; Lutful Kabir, 2009). The intestine harbors a complex
community of trillions of microbes including bacteria, archaea, virus and eukarya. These microbes
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called microbiota, and their metabolic activities and products are collectively defined as the
microbiome (Sun and Jia, 2018). Improved feed efficiency of chickens is associated with different
gut microbiota (Stanley et al., 2013), maybe through extracting nutrients from microbial activities
such as short chain fatty acids (acetate, propionate, butyrate, and lactate), enzymes, amino acids,
and vitamins B and K (Ewing & Cole, 1994) (Yadav & Jha, 2019). Early colonization of the gut
microbiota is important for poultry health and performance (Kers et al., 2018).
Recently, we found that microbial metabolite secondary bile acid deoxycholic acid (DCA)
improves broiler chicken body weight gain (Alrubaye et al., 2019) and prevents Eimeria maxima
and Clostridium perfringens-induced acute necrotic enteritis (Wang et al., 2019). In this study,
we reconstituted chicken intestinal microbial communities using specific pathogen free (SPF)
mouse microbiota. We found that SPF anaerobe and aerobe microbiota improve chicken body
weight gain. The results from this study may help in developing new antimicrobial free
alternatives.
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3.3 Materials and Methods
Chicken feeding and management
All the experiments were approved by the Institutional Animal Care and Use Committee (IACUC)
of the University of Arkansas. The experiments were conducted at JKS Poultry Health Laboratory
at University of Arkansas at Fayetteville. Day old Cobb 500 male broiler chicks were obtained
from Cobb-Vantress (Siloam Springs, AR). Chicks were received, neck-tagged and randomly
assigned to floor pens in an environmentally controlled house. No medication was added to the
feed. Feed and water were supplemented ad libitum and temperature was maintained according to
their age, 34°C for the first 5 days and then gradually decreased to 23°C until final day 27. The
broiler chicks were fed a corn-soybean meal-based starter diet for the first d 0 to 10 and a grower
diet during d 11to 28. The basal diet was formulated as described before (Alrubaye et al., 2019).
Preparation of the microbiota culture and inoculation of day-old chickens
Mouse specific pathogen free (SPF) microbiota were cultured on Brain Heart Infusion (BHI) agar
under anaerobic or aerobic conditions and collected as SPF-Anaero and SPF-Aero, respectively,
similar to the previous report (Sun et al., 2018). Day-old birds were then orally gavaged with a
single dose of 108 CFU/bird SPF-Anaero, or 108 CFU/bird SPF-Aero microbiota and negative
control broiler chickens were gavaged with PBS. The birds were weighed at day 0, 14, and d 28
and were euthanized at d 28.
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Statistical Analysis
Data were first analyzed by One-way ANOVA for significant difference and then t-test was used
for multiple comparison using Prism 7.0 software. Experiments were considered statistically
significant if P values were < 0.05.
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3.4

Results and discussion

Although industrialization of the poultry industry and the use of antimicrobial growth promoters
have greatly improved the production efficiency, issues such as antimicrobial resistance (Caly et
al., 2015) and animal welfare (Ben Sassi et al., 2016), urgently need to be addressed. Among
various differences resulting from poultry industrialization, the disruption of microbiota
transmission from parental sources has been largely overlooked. In this study, we reasoned that
broiler chicks from commercial hatcheries would be colonized with environmental (hatchery,
transportation vehicles, and grower farms) microbiota. The environmental microbiota will not
always be suitable for chicken growth. To test this hypothesis, we reconstituted broiler chicken
microbial communities by transplanting mouse SPF microbiota. The selection of mouse
microbiota was based on our previous observations that SPF mice are resistant to foodborne
pathogen Campylobacter jejuni colonization (Sun et al., 2018) while chickens are susceptible
(Alrubaye et al., 2019).
All the birds grew healthy and the control birds without microbiota transplantation grew to 0.421
kg/bird at d 14. Birds colonized with SPF-Anaero grew 15% heavier during starter period of d 014 (28 vs. 24 g/day/bird, P= 0.0009) compared to control birds without microbiota colonization
(Figure 3.1). Birds colonized with SPF-Aero gained 8% more body weight compared to control
birds (26 vs. 24 g/day/bird, P= 0.02). Consistently, SPF-Anaero birds grew 12% faster compared
to control birds during d14-28 (67 vs. 60 g/day/bird, P= 0.007), while SPF-Aero failed to
significantly increase body weight gain (Figure 3.2). As a result, SPF-Anaero and SPF-Aero birds
grew 15 and 4 %, respectively, heavier on accumulative body weight gain during d 0-28 (Figure
3.3) compared to control birds (47 vs. 42 g/day/bird, P= 0.0009; 44 vs. 42 g/day/bird, P= 0.03,
respectively).
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The underlying mechanism of growth promoting capacity of SPF microbiota is unclear. It is
possible SPF microbiota improves nutrient generation, absorption and utilization as well as
immune response and stress reduction. Interestingly, one of important risk factors affecting
overweight or obesity in humans (Okeke et al., 2014) or mice (Turnbaugh et al., 2006) is the
influence of the gut microbiome. The microbiota from obese mice has an increased capacity to
harvest energy from the diet and this trait is transmissible (Turnbaugh et al., 2006). In our study,
it is possible that SPF microbiota increases energy extraction compared to control birds. Future
research on nutrient digestibility and absorption should be investigated.
The microbiota is essential for the inducing, training, and reacting of the host immune system to
tolerate or against various foreign agents (Belkaid and Hand, 2014). As a result, the host immune
system maintains the symbiotic relationship with the highly diverse and evolving microbiota. Gut
permeability for bacterial translocation is increased during pregnancy and lactation, and dendritic
cells in the milk contribute to neonatal immune imprinting and tolerance (Perez et al., 2007). It
would be helpful to investigate whether the microbiota of SPF-Anaero and SPF-Aero modulate
chicken immune response.
In conclusion, reconstituting chicken microbiota using mouse SPF-Anaero improves the bird
BWG. This finding may be a feasible antimicrobial alternative in poultry production.
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3.5 Figures

Figure 3.1

Periodic daily BWG during d 0-14.

Mouse SPF stool was cultured on BHI agar under anaerobic or aerobic condition and collected as
SPF anaerobic microbiota (SPF-Anaero) and aerobic microbiota (SPF-Aero). Day-old birds were
tagged and placed in six pens (2 pens/group, 16 birds/pen). The birds were orally gavaged with
PBS or 108 CFU/bird SPF-Anaero or SPF-Aero. The bird weight was measured at d 0, 14, and 28.
Showed are periodic daily BWG during d 0-14. All graphs depict mean ± SEM. *P < 0.05;
***P < 0.001.
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Figure 3.2

Periodic body weight gain during d 14-28.

Birds were colonized with SPF-Anaero and SPF-Aero microbiota as in Figure 3.1. Showed are
periodic daily BWG during d 14-28. All graphs depict mean ± SEM. **P < 0.01.
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Figure 3.3

Accumulative body weight gain during d 0-28.

Birds were colonized with SPF-Anaero and SPF-Aero microbiota as in Figure 3.1. Showed are
accumulative daily BWG during d 0-28. All graphs depict mean ± SEM. *P < 0.05; ***P < 0.001.
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4.1 Conclusions
The main objectives of this thesis were to investigate selected microbiota and metabolites ther of
as an alternative to antibiotics for growth promotion and disease prevention. Four chicken
experiments were performed using microbial metabolic product secondary bile acids (DCA), and
SPF anaerobe and aerobe microbiota. Notably, DCA in drinking water prevented NE-induced
BWG reduction and pathological lesions. This could be through reducing C. perfringens
colonization and/or restoring the intestinal bile acid pool. On the other hand, reconstituting chicken
microbiota using mouse SPF-Anaero microbiota improved chicken growth performance. In the
future, specific members of the microbiota could be identified, isolated and applied in the poultry
industry. In conclusion, these findings may offer an alternative strategy to use microbiota and its
metabolite for growth promotion and NE prevention.
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